A new framework for service supply chains T Baltacioglu, E Ada, MD Kaplan, O Yurt And, Y Cem Kaplan The Service Industries Journal 27 (2), 105-124, 2007 | 611 | 2007 |
Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta‐analysis YC Kaplan, J Ozsarfati, C Nickel, G Koren British journal of clinical pharmacology 81 (5), 835-848, 2016 | 115 | 2016 |
Prenatal selective serotonin reuptake inhibitor use and the risk of autism spectrum disorder in children: A systematic review and meta-analysis YC Kaplan, E Keskin-Arslan, S Acar, K Sozmen Reproductive Toxicology 66, 31-43, 2016 | 93 | 2016 |
Effects of acute and subacute garlic supplement administration on serum total antioxidant capacity and lipid parameters in healthy volunteers M Koseoglu, F Isleten, A Atay, YC Kaplan Phytotherapy Research: An International Journal Devoted to Pharmacological …, 2010 | 59 | 2010 |
Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta‐analysis of cohort studies YC Kaplan, E Keskin‐Arslan, S Acar, K Sozmen British journal of clinical pharmacology 83 (12), 2798-2806, 2017 | 55 | 2017 |
Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services A Panchaud, V Rousson, T Vial, N Bernard, D Baud, E Amar, M De Santis, ... British journal of clinical pharmacology 84 (3), 568-578, 2018 | 48 | 2018 |
Pregnancy outcomes following first‐trimester exposure to topical retinoids: a systematic review and meta‐analysis YC Kaplan, J Ozsarfati, F Etwel, C Nickel, I Nulman, G Koren British Journal of Dermatology 173 (5), 1132-1141, 2015 | 48 | 2015 |
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study U Winterfeld, G Klinger, A Panchaud, S Stephens, J Arnon, H Malm, ... Journal of clinical psychopharmacology 35 (3), 250-259, 2015 | 40 | 2015 |
Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information Services JL Richardson, S Stephens, LM Yates, O Diav-Citrin, J Arnon, D Beghin, ... Reproductive Toxicology 67, 26-34, 2017 | 38 | 2017 |
Use of ondansetron during pregnancy and the risk of major congenital malformations: A systematic review and meta-analysis YC Kaplan, JL Richardson, E Keskin-Arslan, H Erol-Coskun, D Kennedy Reproductive Toxicology 86, 1-13, 2019 | 35 | 2019 |
Pregnancy outcomes following quinolone and fluoroquinolone exposure during pregnancy: a systematic review and meta-analysis S Acar, E Keskin-Arslan, H Erol-Coskun, T Kaya-Temiz, YC Kaplan Reproductive Toxicology 85, 65-74, 2019 | 33 | 2019 |
Exposure to fluconazole and risk of congenital malformations in the offspring: a systematic review and meta-analysis AMS Alsaad, YC Kaplan, G Koren Reproductive toxicology 52, 78-82, 2015 | 31 | 2015 |
Use of phenytoin, phenobarbital carbamazepine, levetiracetam lamotrigine and valproate in pregnancy and breastfeeding: risk of major malformations, dose-dependency, monotherapy … YC Kaplan, O Demir Current neuropharmacology 19 (11), 1805, 2021 | 29 | 2021 |
Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects A Gelal, D Balkan, D Ozzeybek, YC Kaplan, S Gurler, H Guven, ... European journal of clinical pharmacology 60, 785-790, 2005 | 29 | 2005 |
Fluconazole use during breastfeeding YC Kaplan, G Koren, S Ito, P Bozzo Canadian Family Physician 61 (10), 875-876, 2015 | 27 | 2015 |
Effect of glucagon on amitriptyline-induced cardiovascular toxicity in rats YC Kaplan, N Hocaoglu, K Oransay, S Kalkan, Y Tuncok Human & experimental toxicology 27 (4), 321-325, 2008 | 24 | 2008 |
İlaçların gebelikte kullanımlarına dair risk iletişiminde yeni dönem: FDA gebelik risk kategorileri değişiyor YC Kaplan, H Can, Ö Demir, B Karadaş, İ Yılmaz, TK Temiz Türkiye Aile Hekimliği Dergisi 18 (4), 195-198, 2014 | 19 | 2014 |
Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study E Pauliat, M Onken, C Weber-Schoendorfer, V Rousson, MC Addor, ... Multiple Sclerosis Journal 27 (3), 475-478, 2021 | 18 | 2021 |
False-positive amphetamine/ecstasy (MDMA/3, 4-methylenedioxymethamphetamine)(CEDIA) and ecstasy (MDMA/3, 4-methylenedioxymethamphetamine)(DRI) test results with fenofibrate YC Kaplan, A Erol, B Karadas Therapeutic Drug Monitoring 34 (5), 493-495, 2012 | 18 | 2012 |
The role of smoking in the development and progression of structural damage in axial SpA patients: A systematic review and meta-analysis S Akar, YC Kaplan, S Ecemiş, E Keskin-Arslan, Ö Gercik, S Gücenmez, ... European journal of rheumatology 6 (4), 184, 2019 | 16 | 2019 |